Indies Pharma Jamaica is reporting that it generated net profits of $45.5 million dollars or 3 cents per share on revenues of $291.73 million during three month-period August 1 to October 31.
The company's assets climbed to $2.29 billion from $2.4 billion and shareholders equity to $1.29 billion, from $1.22 $billion.
Total liabilities dipped to $1 billion from $1.02 billion during the period under review.
comments powered by Disqus
All feeds
